Yokoyama Maki, Miyakoshi Kei, Nakanishi Sayuri, Iwama Noriyuki, Aoki Shigeru, Yasuhi Ichiro, Sugiyama Takashi
Department of Obstetrics and Gynecology, Ehime University Graduate School of Medicine, Shitsukawa, Toon, Ehime 791-0295 Japan.
Department of Obstetrics and Gynecology, International Catholic Hospital, 2-5-1 Nakaochiai, Shinjuku-ku, Tokyo 161-8521 Japan.
Diabetol Int. 2024 Feb 20;15(3):627-631. doi: 10.1007/s13340-024-00700-1. eCollection 2024 Jul.
Our aim is to investigate the obstetric practices in Japan regarding the screening and management of gestational diabetes mellitus (GDM) diagnosed before 20 weeks of gestation (early-GDM). A web-based questionnaire survey was administered to 991 teaching hospitals between November 2021 and February 2022, and 602 responses were received (a response rate of 61%). Screening tests for all pregnant women in the first trimester were conducted in 553 (92%) hospitals, and nearly all of these hospitals (535/553 [97%]) adhered to an individual protocol, predominantly relying on random plasma glucose measurements (488/535 [91%]). A quarter (139 [26%]) implemented a risk profile assessment for GDM screening, taking into account factors such as previous gestational diabetes, prior macrosomia, and family history of diabetes. A small number (23 [4%]) targeted only women at high risk of GDM using the risk profile assessment. The majority of hospitals (501 [94%]) employed a 75 g oral glucose tolerance test as a diagnostic measure, and glycemic control for early-GDM was established in most hospitals (429 [80%]). Of the 535 hospitals that maintained an individual management protocol, 356 [67%] facilitated dietary management, self-monitoring of blood glucose, and insulin administration if needed to meet glycemic targets. Our survey revealed a widespread adoption of universal screening and subsequent treatment for early-GDM in Japan.
我们的目的是调查日本对于妊娠20周前诊断出的妊娠期糖尿病(GDM,即早发型GDM)的筛查和管理的产科实践情况。2021年11月至2022年2月期间,我们对991家教学医院进行了基于网络的问卷调查,共收到602份回复(回复率为61%)。553家(92%)医院对所有孕早期孕妇进行了筛查测试,并且几乎所有这些医院(553家中的535家[97%])都遵循个体化方案,主要依靠随机血糖测量(535家中的488家[91%])。四分之一(139家[26%])的医院在GDM筛查中实施了风险评估,考虑了既往妊娠期糖尿病、既往巨大儿病史以及糖尿病家族史等因素。少数医院(23家[4%])仅针对GDM高危女性进行风险评估筛查。大多数医院(501家[94%])采用75克口服葡萄糖耐量试验作为诊断措施,并且大多数医院(429家[80%])为早发型GDM制定了血糖控制方案。在维持个体化管理方案的535家医院中,356家(67%)提供饮食管理、血糖自我监测,并在需要时给予胰岛素治疗以达到血糖目标。我们的调查显示,日本广泛采用了对早发型GDM的普遍筛查及后续治疗。